Download PDF
Thromb Haemost 1984; 52(03): 336-342
DOI: 10.1055/s-0038-1661209
Original Article
Schattauer GmbH Stuttgart

The Calibration of the Second Primary International Reference Preparation for Thromboplastin (Thromboplastin, Human, Plain, Coded BCT/253)

Jean M Thomson
The UK Reference Laboratory for Anticoagulant Reagents and Control, Withington Hospital, Manchester, UK
,
J A Tomenson
The UK Reference Laboratory for Anticoagulant Reagents and Control, Withington Hospital, Manchester, UK
,
L Poller
The UK Reference Laboratory for Anticoagulant Reagents and Control, Withington Hospital, Manchester, UK
› Author Affiliations
Further Information

Publication History

Received 25 May 1984

Accepted 03 October 1984

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

An international collaborative exercise has been undertaken to calibrate a replacement for the first WHO primary international reference preparation (IRP) for thromboplastin. The replacement preparation is a lyophilised batch of British Comparative Thromboplastin (BCT/253, human plain) for use in the Quick prothrombin time test. Seventeen centres participated. The experimental design, calibration model and statistical analysis were based on the recommended WHO procedure. As a result of this calibration exercise an International Sensitivity Index (ISI) of 1.1 has been assigned to the preparation by WHO and it has been officially recognised as the second primary IRP for thromboplastin.

The calibration of BCT/253 is an essential link in a new hierarchical structure for the standardisation of the prothrombin time. The aim is to provide a uniform international system of reporting prothrombin time results using International Normalised Ratios (INR) derived from the ISI of individual thromboplastins.

Key words

International reference thromboplastin - Thromboplastin calibration - Prothrombin time standardisation
 

  • References

  • 1 Ingram GI C. The stability of the WHO reference thromboplastin NIBS and C 67/40. Thromb Haemostas 1979; 42: 1135-1140
    PubMedGoogle Scholar
  • 2 Hills M, Ingram GI C. Monitoring successive batches of British Comparative Thromboplastin. Br J Haematol 1973; 25: 334-451
    PubMedGoogle Scholar
  • 3 Bailey EI, Harper TA, Pinkerton PH. The “therapeutic range” of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations. Can Med Ass J 1971; 105: 1041-1044
    PubMedGoogle Scholar
  • 4 Bain B, Forster T, Sleigh B. Control of oral anticoagulants by the prothrombin time: a plea for uniformity. Aust J Med 1978; 2: 459-461
    PubMedGoogle Scholar
  • 5 Bradlow BA, Saunder C, Whitbread P, Lurie A, Penfold GK, Metz J. Standardisation of the laboratory control of anticoagulant therapy. S A Med J 1974; 48: 1857-1862
    PubMedGoogle Scholar
  • 6 Brink S, Cloete H, Roberts R, Holm W. Laboratoriumsstandaar- disasie en kwaliteitskontrole in Antistolterapie. S A Med J 1976; 50: 205-208
    PubMedGoogle Scholar
  • 7 Korsan-Bengtsen K, Johsen M, Pehrsson NG. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (Simplastin A) based on fresh plasma samples from dicoumarol-treated patients. Thromb Haemostas 1977; 37: 98-103
    PubMedGoogle Scholar
  • 8 Talalak P. Current oral anticoagulant practice and its laboratory control in Thailand: II. Comparison of rabbit brain and human brain thromboplastin, calibration against standard reference thromboplastin. J Med Ass Thai 1979; 62: 618-629
    PubMedGoogle Scholar
  • 9 Tankovski I, Lisichkov T, Angelova TS V, Buchvarova V. Study of the standardized Bulgarian thromboplastin for prothrombin time determination. Contemp Med 1977; 28: 40-43
    PubMedGoogle Scholar
  • 10 Zucker S, Brosious E, Cooper GR. One-stage prothrombin time survey. Am J Clin Pathol 1970; 53: 340-347
    CrossrefPubMedGoogle Scholar
  • 11 WHO Expert Committee on Biological Standardisation. 34th Report. WHO Technical Report Series; 1983. 700 19
    Google Scholar
  • 12 Loeliger EA, van den Besselaar AM H P, Hermans J, van der Velde EA. Certification of three reference materials for thromboplastins. BCR Information. Commission of the European Communities. Brussels: 1981
    Google Scholar
  • 13 Hermans J, van den Besselaar AM H P, Loeliger EA, van der Velde EA. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemostas 1983; 50: 712-717
    PubMedGoogle Scholar
  • 14 WHO Expert Committee on Biological Standardisation. 33rd Report. WHO Technical Report Series; 1983. 687 81-105
    Google Scholar
  • 15 Kirkwood TB L. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemostas 1983; 49: 238-244
    PubMedGoogle Scholar
  • 16 Kendall MG, Stuart A. The Advanced Theory of Statistics. Charles Griffin; London: 1972. 2 391-435
    Google Scholar
  • 17 Tomenson JA. A statistician’s independent evaluation. In: Van den Besselaar AM H P, Gralnick HR, Lewis SM. (eds) Thromboplastin Calibration and Oral Anticoagulant Control. Martinus Nijhoff; The Hague: 1984. pp 87-108
    Google Scholar
  • 18 Poller L, Thomson JM, Yee KF. Stability studies on lyophilized reference thromboplastins for standardisation of prothrombin times. Lancet 1977; 2: 1019-1022
    PubMedGoogle Scholar
  • 19 Van den Besselaar AM H P, Van Halem-Visser LP, Loeliger EA, Hermans J. Stability of international reference thromboplastins. Br J Haematol 1980; 45: 153-160
    CrossrefPubMedGoogle Scholar
  • 20 Stevenson KJ, Slater PJ, Poller L. The British Comparative Thromboplastin: The relationship between lipid class composition and procoagulant activity. Br J Haematol 1980; 44: 495-501
    CrossrefPubMedGoogle Scholar